The Wooden Mirror: A Psychiatrists’ Perspective from an Iboga Microdosing Container

Recently, I joined a six-week iboga microdosing “container” - a small group of people, guided by facilitators trained in a South African lineage and Western psychology, working with tiny pieces of root bark from a Central African shrub. Four days on, three days off. Chewing it, not capsuling it. Tasting the bitterness. Noticing what comes up.

If you'd told me ten years ago that I'd be writing about this on my professional blog, I would have had questions. But I've spent the last several years of my career bridging worlds - the evidence based research-heavy Western psychiatry and psychology world - with that of shamanic, anamistic, and mystical wisdom traditions.

They do have a lot to teach each other, it turns out.

PS: I’ll add later what it means to be in a container and what the major differences are between levels of dosing (micro, stream, flood). Because it matters.

Also, scroll down for safety PSA: I only work with these medicines in highly reverent contexts and it’s important to know there are real health considerations to take into account!

Here's what caught my attention.

The Mirror

One of the facilitators in my container described their first experience with iboga: They were struck by how the medicine “thought and worked just like him!” (again, in these worlds you’ll notice an (almost?) anthropomorphized relating to “the medicine” as a teacher.

People experienced in iboga will describe it as feeling more like… yourself. That with LSD and psilocybin, it sometimes feels like something else, from out there, from separate from you, coming in. But with iboga, it does have it’s own “signature” but it’s… “you but more”. They described iboga as immersing them in a more grounded, honest, compassionate, observing version of himself (a common theme in all great psychedelic, healing, and therapy work).

They described iboga as a mirror, a ”woody mirror." It reflects you back to you, but with the lights turned up (again, a common outcome of many plant medicines and healing work - we’ll have to see how exactly this has its own way of doing this).

They noted that your habitual postures (literal and metaphorical), your looping patterns (thoughts and behaviors), the ways you navigate life without realizing you're doing it. The blind spots become slightly less blind. Not through revelation, but through a kind of gentle, persistent clarity.

He compared it to learning facets of bodywork practice (they were learning facets of The Alexander Technique): The way you brace your shoulders without knowing it. The way you lean forward when you're anxious. Iboga does the same thing, except not just with your physical posture. With your posture in life. How you parent. How you partner. How you work. How you relate to money, to time, to conflict, to god perhaps.

When I heard this, I leaned forward. Because what he was describing, in the language of his tradition, maps almost perfectly onto what I spend my clinical days trying to help people develop: metacognition. The capacity to observe your own patterns from a slight distance, without being fully captured by them. And in that embodied observation, choose anew.

In therapy, we work for months, sometimes years, to help someone develop that observer position. Internal Family Systems calls it "Self" energy. Mindfulness traditions call it witness consciousness. ACT calls it observer mind. DBT calls it Wise Mind.

Victor Frankl (Man’s Search for Meaning) called it the pause between stimulus and response:

“Between stimulus and response there is a space.

In that space is our power to choose our response.

In our response lies our growth and our freedom.”

Of course, practiced meditators know that this space can be cultivated and trained with various practices over time. The rest of us know that simple is NOT easy.

And experienced psychedelic practitioners will emphasize that a glimpse into that experience is just the beginning: your integration (continued practice, in any way that will be uniquely do-able for you) is what creates the unsexy, unglamorous 1% shifts over time that eventually really do add up to something - neurologically paving new pathways, psychologically paving new ways of being.

Iboga, even at microdosing levels, appears to support this naturally (as a start). Not dramatically. Subtly.

What Iboga Actually Is

(and Where It Comes From)

I want to be careful here. There's a version of this section that reads like a Wikipedia entry, and you don't need that from me. But you do need some context, because iboga is not a lab-made compound. It comes from a living lineage, and that matters.

Iboga (Tabernanthe iboga) is a rainforest shrub from West Central Africa - Gabon, Cameroon, the Congo Basin. Its root bark contains over 30 alkaloids, the best-known being ibogaine. It has been used for centuries, possibly millennia, within the Bwiti spiritual tradition, practiced by the Babongo, Mitsogho, and other peoples. Gabon declared iboga a national treasure in 2000. The Bwiti tradition is oral and experiential, not written. It's not a religion in the Western sense. Practitioners describe it as the direct study of life.

One concept from the tradition that was shared: Bokhaye (M'BOKAYE), a term from the Bwiti/Guiti tradition meaning "we are together" or "everything is together." It's an animist principle - everything is alive, everything is in relationship, nothing is separate. This is the basic operating system of the tradition iboga comes from. It’s animistic and deeply relational. Is it the placebo effect on steroids? Maybe! I also don’t want to cheapen the tradition my squeezing it only into my tiny mechanistically trained view. It’s a rich question for another day.

I notice something in myself when I write about this. The clinician in me wants to translate everything into Western psychological language, because that's my fluency and that's what my patients expect. But part of what drew me to this container is the recognition that the Western clinical lens is one framework among many - and for iboga specifically, it's not the primary one. I don't need to become an expert in Bwiti cosmology (apart from the respectful basic learning and acknowledgement to pay homage to its source). But I do need to be honest about where I'm standing and what I'm drawing from.

So: I am a Western psychiatrist, Romanian-born, California-based, entering into relationship with a tradition that is not mine, guided by people who hold it with much more depth than I do. I'm bringing my clinical training to make sense of what I encounter. And I'm trying to do that without flattening the experience.

The Dosing Spectrum (and Why I'm a Boogie Boarder)

Most people who've heard of iboga associate it with the flood dose: 12 to 40+ grams of root bark, a 24-to-36-hour visionary experience, medical monitoring required. It’s a wild ride, I have been told.

This is what the Stanford research used (more on that shortly). It's the dramatic, sometimes life-rearranging end of the spectrum. It's also, frankly, intense. It can be confusing, overwhelming, and not always well-held depending on the setting. Fatalities have been reported, primarily during detox procedures, related to ibogaine's effect on cardiac rhythm.

On the other end: microdosing. Pinky-nail-sized pieces of bark, 0.3 to 1.5 grams, four days on, three off. Sub-perceptual, or barely so. You go about your life. In Bwiti tradition, this is called the "hunter's dose" - used for focus, energy, and what amounts to spiritual maintenance. It's not a lesser version of the flood dose. It's its own practice with its own purpose.

In between sits what practitioners call a "stream dose" - maybe 4 to 8 grams. Perceptual but not visionary. More than a nudge, less than an earthquake. Harder to manage going about daily life on.

I’m a boogie-boarder. Not a surfer. And it’s about high time I admitted it.

This has been a personal process years in the making. And perhaps a deeper reflection for another time. While I have experienced stream/flood dosing with other substances - or master teachers - recently, I’ve been leaning into the unique benefits of low, slow, gentle dosing. One that allows us to really lean in to more of this “relationship” quality (again - is it really with the plant or plant spirit or “god” or with our own inner wisdom - who is to really say, and I bet we’re eons away from that in the research world, if that can ever be directly addressed with our tools).

I don't want to chase intensity. I want to build a slow, steady relationship. To take time to digest and practice what I’m learning. (Again, one of the great gifts of all good therapy - pronounced in psychedelic and plant medicine work - IS in fact this concept of agency, empowerment, inner locus of control).

This spectrum maps onto something I already think about with ketamine in my practice. I've been developing a framework for ketamine treatment that positions different approaches along a continuum: purely procedural on one end (minimal therapeutic context), deeply psychotherapy-integrated on the other (lower or carefully calibrated doses, relational container, emphasis on what you do with the experience afterwards). The pharmacological event is one thing. In this view: The integration and behavioral change are the actual work.

Iboga's dosing spectrum carries the same logic. The flood dose is the deep surgery. The microdose is the ongoing relationship. And within traditional Bwiti practice, they don't rank these - they serve different purposes. The Western tendency to see the flood dose as the "real" thing and microdosing as a diluted version misses something important.

What the Research Actually Shows

I want to be straight with you about the evidence, because some of what's written about iboga online gets ahead of the data, and I'm not going to do that here.

The strongest findings come from flood-dose research. The Stanford MISTIC study (Cherian et al., 2024, Nature Medicine) tracked 30 Special Operations veterans with traumatic brain injuries who received magnesium-ibogaine treatment at a clinic in Mexico. One month later: 88% reduction in PTSD symptoms, 87% reduction in depression, 81% reduction in anxiety. Disability scores went from moderate disability to no disability. Brain imaging showed signs of neural repair. A 2025 follow-up found increased cortical thickness and a reduction in predicted brain age by 1.6 years after a single treatment. Texas subsequently committed $50 million to fund clinical trials. These numbers are striking enough that they've shifted the conversation nationally.

The neuroscience underneath is interesting. Ibogaine has an unusually broad pharmacological profile - it interacts with serotonin, dopamine, opioid, NMDA, and nicotinic acetylcholine systems simultaneously. Animal studies show it upregulates GDNF (glial cell line-derived neurotrophic factor), BDNF (brain-derived neurotrophic factor), and NGF (nerve growth factor) in brain regions involved in reward circuitry and cognition. GDNF is especially notable because ibogaine appears to be the only known compound that naturally stimulates its release. Noribogaine, ibogaine's longer-acting metabolite, has been classified as a "psychoplastogen" - a substance that promotes structural neural plasticity.

The theory behind microdosing maintenance is that periodic low doses may sustain noribogaine levels and extend the neuroplasticity window that a flood dose opens. Pharmacokinetically, this is plausible. Clinically, it's unproven.

For microdosing specifically, the published evidence consists of exactly one case report: a 2022 paper in the Brazilian Journal of Psychiatry describing ibogaine microdosing (4mg twice daily for 60 days) in a patient with bipolar II depression, showing progressive improvement that persisted even after stopping. This is hypothesis-generating, not conclusive at all.

So where does that leave us? With strong flood-dose data, compelling neurobiology, reasonable pharmacokinetic rationale for microdosing, and almost no clinical microdosing data. I think this is a space that deserves serious investigation. I don't think it's a space for any confident claims.

The Safety Part

The heart: Ibogaine affects cardiac repolarization through hERG potassium channel blockade, prolonging the QT interval. At flood doses, this has caused fatal arrhythmias. At microdoses, the risk is much lower but not zero. If you are considering this, you absolutely must be in touch with your doctor or psychiatrist about your potential situation. They may even need an EKG from you. For flood dosing, EKG’s and continual medical are required.

Drug interactions: Ibogaine is metabolized by the CYP2D6 enzyme in the liver. Common psychiatric medications that inhibit this enzyme are fluoxetine, paroxetine, bupropion, duloxetine - and can dangerously slow ibogaine metabolism (raising levels much too high). Combining ibogaine with serotonergic medications risks serotonin syndrome. If you're on psychiatric medications and considering any level of iboga work, you need a clinician involved. Tapering, if appropriate, needs to be done carefully and with support. Even for microdosing, participants are asked to abstain from many medications, including common substances like caffeine and alcohol.

Stimulants and caffeine: Participants are advised to avoid even coffee during their process. For anyone with a deep coffee habit (or “a deep relationship with the coffee plant”), this is a big ask. But it's both a pharmacokinetic precaution and a therapeutic one. This reduces the chance of heart rythym complications and other concerning interactions. It’s also symbolic and intentional: clearing away the habitual substances creates space for something new to be felt, and re-enforcing intention. It's a similar logic behind any good therapeutic frame: you need a container with some boundaries to notice what arises within it and against it.

Why I Think This Matters

I'll tell you what I keep coming back to. In my practice, I use psychodynamic therapy, TEAM-CBT, Brainspotting, and ketamine-assisted psychotherapy. All of these, in different ways, are trying to do the same fundamental things: help people see their own patterns, create some distance from automatic reactions, and make new choices from that distance. The therapeutic relationship and “container” itself is the mirror. The clinician's attuned presence creates the conditions for the patient to see themselves more clearly.

What iboga practitioners describe is something like an internalized version of that mirror. One that stays with you between sessions. That gently keeps showing you where you brace, where you avoid, where your habitual patterns run things without your conscious participation. And it does this - if the reports are to be believed - with a quality of sovereignty. It shows, but it doesn't prescribe. You still choose. That's an empowering frame, and it's different from a lot of psychedelic narratives that lean hard on "surrender” (which is still important, but this frame leans more on agency).

I'm early in this. I don't have my own full experiential arc to share yet. What I have is clinical curiosity, a growing sense that iboga - particularly in its microdosing form - deserves much more serious attention from the psychiatric community, and the conviction that when something this old and this well-held by its tradition of origin starts producing data this interesting in Western research settings, paying attention is not just reasonable. It's a responsibility.

This medicine comes from Central African forests tended by families who have been connected to that land for hundreds of thousands of years. The trees are harvested by hand. They die when they're harvested. That root bark traveled across the world to end up in my hands. I think the least I can do is pay very close attention to what it has to say.

Get in Touch

If you're someone experienced in iboga or other plant medicines and you'd like to share information, updates, clarification, or other insights - please do!

If you're a clinician curious about iboga or psychedelic-assisted work, I'm always happy to connect.

Reach out through my collaboration page or email drpop@patriciapopmd.com.

——

Hello! I'm Patricia Pop, MD - a board-certified psychiatrist based in Half Moon Bay, California offering remote psychiatry and therapy throughout California.

I offer integrative psychotherapy and medication management for adults, including psychodynamic therapy, CBT, brainspotting, and low-dose ketamine-assisted psychotherapy (see ketamineprep.com for my preparation guide). I work at the intersection of evidence-based psychiatry and relational healing - including psychedelic and altered-state assisted modalities. I love to write about the places where clinical science and experiential wisdom meet. Visit patriciapopmd.com or book at pop.intakeq.com/booking.

This post is for educational purposes only. Ibogaine is a Schedule I controlled substance in the United States. Nothing here constitutes medical advice or an endorsement of any illegal activity